New dog and new tricks: evolving roles for IL-33 in type 2 immunity (Q38388349)

2 September 2017

1 reference

title

New dog and new tricks: evolving roles for IL-33 in type 2 immunity (English)

1 reference

2 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Jeremy M Lott

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Tina L Sumpter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

23 March 2015

1 reference

Journal of Leukocyte Biology

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1037-1048

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Regulation of T cell immunity by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

CD4 T cells: fates, functions, and faults

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

21 January 2018

Immunobiology of asthma

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-9 and Th9 cells: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

21 January 2018

IL-13 effector functions

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Cytokine mediated tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Differential regulation of IgG1 and IgE synthesis by interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Implications for Interleukin-33 in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 mediates inflammatory responses in human lung tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33 is biologically active independently of caspase-1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 exacerbates antigen-induced arthritis by activating mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin 33 as a mechanically responsive cytokine secreted by living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33 - cytokine of dual function or novel alarmin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 is a crucial amplifier of innate rather than acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Alarmins: awaiting a clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The alarmin IL-33 promotes regulatory T-cell function in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33 prolongs allograft survival during chronic cardiac rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

An essential role of the transcription factor GATA-3 for the function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 is a chemoattractant for human Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

New paradigms in type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Innate lymphoid cells in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Programming dendritic cells to induce T(H)2 and tolerogenic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33-activated dendritic cells induce an atypical TH2-type response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

A large-scale, consortium-based genomewide association study of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Increased IL-33 expression by epithelial cells in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Signaling through FcRγ-associated receptors on dendritic cells drives IL-33-dependent TH2-type responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Monocytes and macrophages: developmental pathways and tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

ST2 and IL-33 in pregnancy and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IgE and mast cells in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Regulation of mast-cell and basophil function and survival by IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Murine mast cells secrete and respond to interleukin-33

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 can promote survival, adhesion and cytokine production in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

A20-deficient mast cells exacerbate inflammatory responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 induces IL-9 production in human CD4+ T cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33/ST2 axis promotes mast cell survival via BCLXL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Eosinophils: changing perspectives in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

A critical role of IL-33 in experimental allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Basophils: a nonredundant contributor to host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Innate lymphoid cells--how did we miss them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Type 2 innate lymphoid cells drive CD4+ Th2 cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Transcription factor RORα is critical for nuocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Liver fibrosis: cellular mechanisms of progression and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Immune interactions in hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Interleukin-33 potentiates bleomycin-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 promotes Staphylococcus aureus-infected wound healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

Basophil-Derived Interleukin-4 Controls the Function of Natural Helper Cells, a Member of ILC2s, in Lung Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3RI1214-595R

21 January 2018

Identifiers

DOI

10.1189/JLB.3RI1214-595R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25801770%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference